This mapping review highlights the need for a new paradigm in the understanding of peri- implantitis pathogenesis. The biofilm-mediated inflammation and bone dysregulation (BIND) …
N Zhu, H Ni, S Guo, YQ Shen, Q Chen - Cancer Treatment Reviews, 2024 - Elsevier
With the advancements in conventional treatment modalities such as radiation, chemotherapy, and surgery, as well as the emergence of immunotherapy, the overall cure …
G Dipalma, AM Inchingolo, G Malcangi, I Ferrara… - Bioengineering, 2023 - mdpi.com
Aims: Medication-related osteonecrosis of the jaw (MRONJ) is a drug-related adverse reaction characterized by bone destruction and necrosis in the jaw. This case series aims to …
A Muñoz-Salgado, FFV e Silva… - … oral, patologia oral y …, 2023 - ncbi.nlm.nih.gov
Background Osteonecrosis of the jaw (ONJ) has a frequent adverse effect after the administration of nitrogenous bisphosphonates, as non-nitrogenous bisphosphonates are …
Purpose The aim of this study was to evaluate changes in the trabecular bone through texture analysis and compare the texture analysis characteristics of different areas in …
C Gaudet, S Odet, C Meyer, B Chatelain, E Weber… - Cells, 2022 - mdpi.com
Medication-related osteonecrosis of the jaw (MRONJ) is a complication caused by anti- resorptive agents and anti-angiogenesis drugs. Since we wanted to write a protocol for a …
RA Mokhtari, M Olsson, PO Östman… - … Implant Dentistry and …, 2024 - Wiley Online Library
Objective To evaluate patient safety, implants survival and implant stability of the bisphosphonate (zoledronate) as a coating on dental implants in patients requiring oral …
D Heimes, NA Mark, R Kuchen, A Pabst, P Becker… - Medicina, 2023 - mdpi.com
Background: The role of medication-related osteonecrosis of the jaw (MRONJ) as a dento- maxillo-facial pathology is becoming increasingly important due to its growing prevalence …
Y Tanaka, KT Aung, M Ono, A Mikai, AT Dang… - International journal of …, 2021 - mdpi.com
Medication-related osteonecrosis of the jaw (MRONJ) is related to impaired bone healing conditions in the maxillomandibular bone region as a complication of bisphosphonate …